Evaluating the relationship between the proportion of X-chromosome deletions and clinical manifestations in children with turner syndrome

Front Endocrinol (Lausanne). 2024 Feb 28:15:1324160. doi: 10.3389/fendo.2024.1324160. eCollection 2024.

Abstract

Purpose: Analyze the relationship between changes in the proportion of X-chromosome deletions and clinical manifestations in children with Turner syndrome (TS).

Methods: X-chromosome number abnormalities in 8,635 children with growth retardation were identified using fluorescence in situ hybridization (FISH). Meanwhile, the relationship between the proportion of X-chromosome deletions and the clinical manifestations of TS, such as face and body phenotype, cardiovascular, renal, and other comorbidities in children with TS was analyzed.

Results: A total of 389 children had X-chromosome number abnormalities, with an average age at diagnosis of 9.2 years. There was a significant increase in diagnoses around the ages of 3 and 7 years and highest number of diagnoses at 10 years of age. 130 with XO (complete loss of an X-chromosome), 205 with XO/XX, 8 with XO/XXX, 23 with XO/XX/XXX, 19 with XO/XY, and 4 with XO/XY/XYY. Body and facial phenotypes increased with higher mosaicism proportions, with a relatively high correlation shown with Pearson correlation analysis (r = 0.26, p = 1.7e-06). The incidence of congenital heart malformations was 25.56%, mainly involving a bicuspid aortic valve, and were more common in patients who had complete loss of an X-chromosome. However, this relationship was not present for renal disease (p = 0.26), central nervous system, thyroid, or liver disease.

Conclusion: The mosaicism (XO/XX) is the most common karyotype of TS in screened cases. The phenotypes in children with TS may increase with the proportion of X-chromosome deletions, but the renal disease and comorbidities did not show the same characteristics.

Keywords: X-chromosome; mosaicism; phenotype; short stature; turner syndrome.

MeSH terms

  • Child
  • Chromosome Deletion
  • Chromosomes, Human, X / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Kidney Diseases* / genetics
  • Turner Syndrome* / complications
  • Turner Syndrome* / epidemiology
  • Turner Syndrome* / genetics

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from Henan Province Medical Science and Technology Research Joint Project (LHGJ20220751).